Acb stock forecast 2025 revenue outlook is a critical factor

US $256.00
List price US $226.000 (23% off)
777 sold
This one's trending. 23256 have already sold.
Breathe easy. Returns accepted.

Revenue outlook is a critical factor for "ACB stock forecast 2025". If Aurora can increase medical cannabis exports by 15% year-over-year, valuations may rise significantly despite sector-wide headwinds. SNDL (NASDAQ: SNDL ), which you may remember from its prior corporate name, Sundial Growers, started off as a Canada-based cannabis pure play. In more recent years, however, the company has diversified. Alongside cannabis cultivation and retail operations, SNDL has made substantial debt and equity investments in other cannabis companies. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 46% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. RSI trends suggest accumulation phases are underway.